Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

Clinical trial NCT00625560 · COMPLETED

Trial details

NCT number: NCT00625560
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2008-02-01
Primary completion: 2009-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.